We just received data on a new analyst forecast for $UTI. Barrington Research gave a rating of 'Outperform' for $UTI.
$UTI Analyst Ratings
Wall Street analysts have issued reports on $UTI in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 07/29/2025
- Truist Securities issued a "Buy" rating on 05/22/2025
- Lake Street issued a "Buy" rating on 05/21/2025
- Rosenblatt issued a "Buy" rating on 05/08/2025
- Northland Capital Markets issued a "Outperform" rating on 02/06/2025
To track analyst ratings and price targets for $UTI, check out Quiver Quantitative's $UTI forecast page.
$UTI Price Targets
Multiple analysts have issued price targets for $UTI recently. We have seen 5 analysts offer price targets for $UTI in the last 6 months, with a median target of $36.0.
Here are some recent targets:
- Alexander Paris from Barrington Research set a target price of $36.0 on 07/29/2025
- Jasper Bibb from Truist Securities set a target price of $40.0 on 05/22/2025
- Eric Martinuzzi from Lake Street set a target price of $38.0 on 05/21/2025
- Steve Frankel from Rosenblatt set a target price of $36.0 on 05/08/2025
- Mike Grondahl from Northland Capital Markets set a target price of $34.0 on 02/06/2025
$UTI Insider Trading Activity
$UTI insiders have traded $UTI stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $UTI stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, LLC COLISEUM has made 0 purchases and 4 sales selling 4,134,369 shares for an estimated $126,304,273.
- SHERRELL SMITH (EVP, Chief Academic Officer) has made 0 purchases and 10 sales selling 106,773 shares for an estimated $2,910,733.
- JEROME ALAN GRANT (Chief Executive Officer) sold 56,492 shares for an estimated $1,909,429
- CHRISTOPHER E. KEVANE (EVP and Chief Legal Officer) has made 0 purchases and 2 sales selling 29,400 shares for an estimated $1,003,260.
- TODD A HITCHCOCK (EVP/COO) has made 0 purchases and 2 sales selling 27,500 shares for an estimated $917,470.
- GEORGE W. BROCHICK has made 0 purchases and 2 sales selling 14,000 shares for an estimated $411,799.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$UTI Hedge Fund Activity
We have seen 128 institutional investors add shares of $UTI stock to their portfolio, and 97 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WASATCH ADVISORS LP added 2,248,338 shares (+inf%) to their portfolio in Q1 2025, for an estimated $57,737,319
- CONGRESS ASSET MANAGEMENT CO added 1,866,779 shares (+inf%) to their portfolio in Q2 2025, for an estimated $63,265,140
- COLISEUM CAPITAL MANAGEMENT, LLC removed 1,704,881 shares (-24.9%) from their portfolio in Q1 2025, for an estimated $43,781,344
- DUMAC, INC. removed 1,681,681 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $43,185,568
- LORD, ABBETT & CO. LLC added 1,077,076 shares (+58.3%) to their portfolio in Q1 2025, for an estimated $27,659,311
- HOOD RIVER CAPITAL MANAGEMENT LLC added 1,021,592 shares (+inf%) to their portfolio in Q1 2025, for an estimated $26,234,482
- DRIEHAUS CAPITAL MANAGEMENT LLC added 803,402 shares (+inf%) to their portfolio in Q1 2025, for an estimated $20,631,363
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
